Behçet's Disease: An Overview of Etiopathogenesis
- PMID: 31134098
- PMCID: PMC6523006
- DOI: 10.3389/fimmu.2019.01067
Behçet's Disease: An Overview of Etiopathogenesis
Abstract
Behçet's disease (BD) is a systemic inflammatory disease with a chronic, relapsing-remitting course of unknown etiology hallmarked predominantly by mucocutaneous lesions and ocular involvement. BD shares some common features with autoimmune and autoinflammatory diseases and spondyloarthropathies (MHC-I-opathies). It is related to more than one pathogenic pathway triggered by environmental factors such as infectious agents in genetically predisposed subjects. The interplay between genetic background and immune system is linked to the BD presentation. Genetic factors have been investigated extensively, and several recent genome-wide association studies have confirmed HLA-B*51 to be the strongest genetic susceptibility factor. However, new non-HLA susceptibility genes have been identified. Genetic variations in the genes encoding the cytokines could affect their function and be associated with disease susceptibility. Infectious agents such as Streptococcus sanguinis or the differences in salivary or gut microbiome composition can be considered to trigger the innate-derived inflammation, which is, subsequently, sustained by adaptive immune responses. Altered trimming of microbial and/or endogenous peptides by endoplasmic reticulum aminopeptidase 1 (ERAP1), presented by HLA-B*51, may play a key role in BD pathogenesis causing an alteration in T cell balance with downregulation of Tregs and expansion of Th1 and Th17. The activity of neutrophils is increased and there is an intense neutrophil infiltration in the early stage of inflammation in organs affected by the disease. Association with HLA-B*51 and increased IL-17 response seems to have an important role in neutrophil activity. In this paper, we provide an overview of the most recent advances on BD etiopathogenesis.
Keywords: Behçet's disease; etiology; genetics; immunology; infectious agents.
Figures
Similar articles
-
Behçet's disease: An immunogenetic perspective.J Cell Physiol. 2019 Jun;234(6):8055-8074. doi: 10.1002/jcp.27576. Epub 2018 Oct 20. J Cell Physiol. 2019. PMID: 30341905 Review.
-
New insights into the pathogenesis of Behçet's disease.Autoimmun Rev. 2012 Aug;11(10):687-98. doi: 10.1016/j.autrev.2011.11.026. Epub 2011 Dec 11. Autoimmun Rev. 2012. PMID: 22197900 Review.
-
A comprehensive overview on the genetics of Behçet's disease.Int Rev Immunol. 2022;41(2):84-106. doi: 10.1080/08830185.2020.1851372. Epub 2020 Dec 1. Int Rev Immunol. 2022. PMID: 33258398
-
[Pathophysiology of Behçet's disease].Rev Med Interne. 2014 Feb;35(2):90-6. doi: 10.1016/j.revmed.2013.10.012. Epub 2013 Nov 6. Rev Med Interne. 2014. PMID: 24210264 Review. French.
-
Role of IL-12B promoter polymorphism in Adamantiades-Behcet's disease susceptibility: An involvement of Th1 immunoreactivity against Streptococcus Sanguinis antigen.J Invest Dermatol. 2006 Jul;126(7):1534-40. doi: 10.1038/sj.jid.5700203. Epub 2006 Mar 2. J Invest Dermatol. 2006. PMID: 16514412
Cited by
-
Behçet's Disease in Children: Diagnostic and Management Challenges.Ther Clin Risk Manag. 2020 Jun 11;16:495-507. doi: 10.2147/TCRM.S232660. eCollection 2020. Ther Clin Risk Manag. 2020. PMID: 32606709 Free PMC article. Review.
-
Pathogenesis of Behçet's Syndrome: Genetic, Environmental and Immunological Factors.Front Med (Lausanne). 2021 Oct 8;8:713052. doi: 10.3389/fmed.2021.713052. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34692721 Free PMC article. Review.
-
Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease.Front Immunol. 2021 Dec 22;12:724900. doi: 10.3389/fimmu.2021.724900. eCollection 2021. Front Immunol. 2021. PMID: 35003055 Free PMC article.
-
Refractory neuro-Sweet disease successfully treated with tocilizumab and mycophenolate mofetil.Encephalitis. 2021 Jan;1(1):20-24. doi: 10.47936/encephalitis.2020.00059. Epub 2020 Dec 24. Encephalitis. 2021. PMID: 37492496 Free PMC article.
-
Clinical Manifestations and Diagnosis of Axial Spondyloarthritis.J Clin Rheumatol. 2021 Dec 1;27(8):e547-e560. doi: 10.1097/RHU.0000000000001575. J Clin Rheumatol. 2021. PMID: 33105312 Free PMC article. Review.
References
-
- International Study Group for Behçet's disease Criteria for diagnosis of Behçet's disease. Lancet. (1990) 335:1078–80. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous